Nanobiotix Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,328	943	143	313	126	254
Market Cap Growth	716.83%	558.09%	-54.17%	147.96%	-50.42%	-46.44%
Enterprise Value	1,275	966	126	345	108	203
Last Close Price	27.40	19.50	3.02	6.64	3.62	7.31
PS Ratio	40.75	28.95	-19.94	8.64	26.42	96.13
PB Ratio	-15.72	-11.17	-2.18	-169.73	-4.66	9.50
P/TBV Ratio	-	-	-	-	-	9.50
EV/Sales Ratio	39.13	29.63	-	9.53	22.66	76.63
Debt / Equity Ratio	-	-	-0.77	-27.44	-1.97	1.72
Net Debt / Equity Ratio	0.62	0.62	-0.02	13.41	-0.44	-1.41
Net Debt / EBITDA Ratio	5.66	5.66	-0.02	1.04	-0.27	0.83
Net Debt / FCF Ratio	1.55	1.55	-0.06	1.93	-0.32	1.26
Asset Turnover	0.48	0.48	-	0.47	0.06	0.02
Quick Ratio	0.95	0.95	0.98	1.68	1.23	2.38
Current Ratio	1.09	1.09	1.04	1.75	1.38	2.53
Return on Equity (ROE)	-	-	-	-	-	-96.66%
Return on Assets (ROA)	-10.00%	-10.00%	-52.89%	-19.72%	-35.38%	-25.00%
Return on Capital Employed (ROCE)	-105.50%	-105.50%	-804.60%	-55.10%	-209.40%	-72.60%
Earnings Yield	-1.80%	-2.54%	-47.53%	-12.69%	-45.21%	-18.47%
FCF Yield	-2.56%	-3.60%	-14.23%	-4.09%	-29.48%	-11.83%
Buyback Yield / Dilution	-1.28%	-1.39%	-27.99%	-5.96%	-0.34%	-42.43%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.